Oncogenic KRAS Induces Arginine Auxotrophy and Confers a Therapeutic Vulnerability to SLC7A1 Inhibition in Non-Small Cell Lung Cancer.
Xiameng GaiYingluo LiuXiaojing LanLuoyi ChenTao YuanJun XuYize LiYing ZhengYiyang YanLiya YangYixian FuShuai TangSiyuwei CaoXiaoyang DaiHong ZhuMeiyu GengJian DingCongying PuMin HuangPublished in: Cancer research (2024)
ASS1 deficiency is induced by mutant KRAS in NSCLC to facilitate DNA synthesis and creates a dependency on SLC7A1, revealing dietary arginine restriction and SLC7A1 inhibition as potential therapeutic strategies.